(Q34984056)

5 August 2017

1 reference

title

Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review (English)

1 reference

5 August 2017

1 reference

hepatocellular carcinoma

1 reference

1 reference

1 reference

1 reference

6

Michael S Torbenson

1 reference

5 August 2017

8

Eric B Bass

1 reference

5 August 2017

1

Kelly A Gebo

1 reference

5 August 2017

Geetanjali Chander

2

1 reference

5 August 2017

Mollie W Jenckes

3

1 reference

5 August 2017

Khalil G Ghanem

4

1 reference

5 August 2017

H Franklin Herlong

5

1 reference

5 August 2017

Samer S El-Kamary

7

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

36

1 reference

5 August 2017

issue

5 Suppl 1

1 reference

5 August 2017

page(s)

S84-92

1 reference

Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Efficacy of a surveillance program for early detection of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Pharmacological treatment of alcohol dependence: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Detection of MAGE-4 protein in the sera of patients with hepatitis-C virus-associated hepatocellular carcinoma and liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Elevation of cytokeratin 19 fragment in serum in patients with hepatoma: its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Urinary transforming growth factor beta1 levels in hepatitis C virus-related chronic liver disease: correlation between high levels and severity of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Frequency of raised alpha-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Clinical utility of simultaneous measurement of serum high-sensitivity des-gamma-carboxy prothrombin and Lens culinaris agglutinin A-reactive alpha-fetoprotein in patients with small hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Soluble interleukin-2 receptor levels in hepatocellular cancer: a more sensitive marker than alfa fetoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Hepatocellular carcinoma in Italian patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

Screening for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36817

21 January 2018

Identifiers

DOI

10.1053/JHEP.2002.36817

1 reference

release_6gczgu76xfhand2qhqralvcdge

5 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6gczgu76xfhand2qhqralvcdge

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference